<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04952740</url>
  </required_header>
  <id_info>
    <org_study_id>2013127</org_study_id>
    <nct_id>NCT04952740</nct_id>
  </id_info>
  <brief_title>Application of Index of Microcirculatory Resistance to Evaluate Myocardial Protection After Ischemic Adaptation</brief_title>
  <official_title>Application of Index of Microcirculatory Resistance to Evaluate Myocardial Protection After Ischemic Adaptation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the protective effect of IPC on the myocardial microcirculation response through&#xD;
      IMR and the predictive value of IMR on the degree of myocardial reperfusion and the prognosis&#xD;
      of patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a clinical randomized controlled study, applying index of microcirculatory&#xD;
      resistance (IMR) to evaluate the myocardial protection of ischemic postconditioning (IPC) in&#xD;
      patients receiving direct PCI treatment for acute myocardial infarction.IMR is a quantitative&#xD;
      evaluation index of microcirculation status. IPC has been reported to reduce&#xD;
      ischemia-reperfusion injury and has a myocardial protective effect.The research plan divides&#xD;
      patients into IPC and non-IPC groups at random. After the infarction-related artery is&#xD;
      successfully implanted with a stent, the pressure guide wire is used to measure IMR and CFR&#xD;
      in the state of maximal expansion of the microcirculation induced by intravenous ATP&#xD;
      infusion.And analyze whether there are differences in indicators between the two groups and&#xD;
      the relationship between these indicators and the patient's myocardial level reperfusion,&#xD;
      cardiac function and prognosis.The purpose is to evaluate the myocardial protection of IPC&#xD;
      and the predictive value of IMR on the degree of myocardial reperfusion and the prognosis of&#xD;
      patients. It is expected that the target IPC can improve the IMR value, and IMR can predict&#xD;
      the degree of myocardial reperfusion and cardiac function and prognosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2014</start_date>
  <completion_date type="Actual">June 30, 2015</completion_date>
  <primary_completion_date type="Actual">December 31, 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IMR</measure>
    <time_frame>detected immediately after percutaneous coronary intervention</time_frame>
    <description>index of microcirculatory resistance measured during coronary intervention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MACEs after PCI</measure>
    <time_frame>6 months</time_frame>
    <description>MACEs includes cardiogenic death, non-fatal myocardial infarction, malignant arrhythmia, unplanned revascularization, unstable angina pectoris requiring hospitalization and severe heart failure requiring hospitalization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Ischemic postconditioning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Routine PCI operations (including thrombus aspiration, stent injection, application of GPIIb/IIIa, etc.) + immediate post-ischemic adaptation: 30 seconds balloon inflation and 30 seconds deflation for 3 cycles</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Ischemic postconditioning</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Routine PCI operations (including thrombus aspiration, stent injection, application of GPIIb/IIIa, etc.)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>IPC+PCI</intervention_name>
    <description>Routine PCI operations (including thrombus aspiration, stent injection, application of GPIIb/IIIa, etc.) + immediate post-ischemic adaptation: 30 seconds balloon inflation and 30 seconds deflation for 3 cycles</description>
    <arm_group_label>Ischemic postconditioning</arm_group_label>
    <other_name>Ischemic postconditioning</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>No IPC</intervention_name>
    <description>Routine PCI operations (including thrombus aspiration, stent injection, application of GPIIb/IIIa, etc.</description>
    <arm_group_label>No Ischemic postconditioning</arm_group_label>
    <other_name>Routine PCI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years old, no gender limit;&#xD;
&#xD;
          -  First episode of STEMI (diagnostic criteria: ischemic chest pain lasting ≥30min;&#xD;
             ST-segment elevation in two or more adjacent leads on the ECG or new left bundle&#xD;
             branch block; with or without elevated myocardial markers), The onset time is within&#xD;
             12 hours, and emergency interventional treatment is planned;&#xD;
&#xD;
          -  Agree and cooperate to participate in this research.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Old myocardial infarction;&#xD;
&#xD;
          -  Killip grade of cardiac function ≥ grade III or cardiogenic shock;&#xD;
&#xD;
          -  Systolic blood pressure ≤100mmHg;&#xD;
&#xD;
          -  Bradycardia, HR&lt;60pbm, or AVB above II degree;&#xD;
&#xD;
          -  Past history of asthma or severe COPD;&#xD;
&#xD;
          -  Severe liver and kidney dysfunction.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lijun Lijun</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University Third Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Peking University third hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100089</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <study_first_submitted>June 29, 2021</study_first_submitted>
  <study_first_submitted_qc>June 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2021</study_first_posted>
  <last_update_submitted>July 8, 2021</last_update_submitted>
  <last_update_submitted_qc>July 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

